Perspective Therapeutics director Robert F. Williamson III reports $20,950 share acquisition
CATX•Director Robert F. Williamson III purchased 25,000 Perspective Therapeutics shares at $0.838 each through the RFW3 Revocable Trust, a $20,950 acquisition.




